Clinical Trials

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT03554109 2025-02-21

TNBC

Triple Negative Breast Neoplasms

NCT05145569 2025-01-01

Antitumor Activity of Neoadjuvant Chemotherapy with or Without HCW9218 in Metastatic Advanced Stage Ovarian Cancer

Ovarian Neoplasms

NCT05177796 2024-10-24

Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer

Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT03841747 2024-03-12

PELICAN

Breast Neoplasms, Neoplasm Metastasis

NCT05998941 2023-11-22

A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer

Uterine Cervical Neoplasms

NCT04989283 2023-09-26

Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05295589 2023-09-26

Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor Therapy

Platinum-Refractory Fallopian Tube Carcinoma

NCT05809895 2023-07-24

AdvanTIG-211

Triple Negative Breast Neoplasms

NCT02067416 2023-02-02

PREDATOR: Neoadjuvant Gene Prediction for Breast Cancer

Breast Neoplasms

NCT05233696 2022-12-06

Radiotherapy in Combo With Chemo and Immunotherapy in Patients With PD-L1 Positive Metastatic TNBC

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05245760 2022-11-08

CRATER

Esophageal Neoplasms

NCT03834571 2022-06-21

Testing the Addition of Paclitaxel and Carboplatin Given After Standard Chemotherapy and Radiation for Cervical Cancer in HIV-positive Women

Uterine Cervical Neoplasms, HIV Infections

NCT04625543 2022-04-26

Neoadjuvant Immunotherapy to ESCC

Esophageal Squamous Cell Carcinoma

NCT04754815 2022-03-29

HFHS 21-01

Carcinoma, Non-Small-Cell Lung

NCT03770299 2022-03-24

CheckMate 9TN

Carcinoma, Non-Small-Cell Lung

NCT02662634 2022-03-18

A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT04038489 2021-11-22

Breast 51

Breast Neoplasms

NCT04262869 2021-10-27

Platinum-Based Chemotherapy and Durvalumab for the Treatment of Stage IIIB or IV Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03872505 2021-08-25

PANDoRA

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04611776 2021-06-16

CATHAYA

Carcinoma, Non-Small-Cell Lung

NCT03699033 2020-11-05

Hypofractionated Radiotherapy With Carboplatin and Paclitaxel in Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT04561817 2020-10-06

To Evaluate the Safety and Efficacy of Ipatasertib (GDC-0068) in Combination With Paclitaxel in Platinum-resistant Recurrent Epithelial Ovarian Cancer

Ovarian Neoplasms, Recurrence

NCT00226746 2020-09-18

Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer

Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

NCT03704077 2020-05-19

An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Stomach Neoplasms

NCT03818997 2020-02-05

DYNAMIC

Biliary Tract Neoplasms, Esophageal Neoplasms

NCT03766607 2019-09-19

Trastuzumab Beyond Progression in HER2 Positive Metastatic Gastric Cancer

Stomach Neoplasms

NCT03058939 2019-04-22

Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer

Breast Neoplasms

NCT03234842 2018-12-21

ES01

Esophageal Neoplasms

NCT02985333 2018-05-14

Paclitaxel,Cyclophosphamide and Dexamethasone for Relapsed or Refractory Multiple Myeloma

Plasma cell

Multiple Myeloma, Recurrence

NCT00003622 2017-07-13

Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

Genitourinary

Prostatic Neoplasms

NCT01205217 2017-06-07

ELATE

Breast Neoplasms

NCT02274012 2017-03-14

Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment

Esophageal Neoplasms, Neoplasm Metastasis

NCT02685306 2017-03-09

A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01179269 2016-10-12

Pazopanib and Paclitaxel for Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT01820312 2016-08-08

A Phase II Study to Evaluate Low-Dose Fractionated Radiotherapy (LDFRT)

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT00768131 2015-10-28

A Study to Determine Whether EGFR Status by FISH Can Predict Results in Non Small Cell Lung Cancer (NSCLC) Patients Treated With Cetuximab, Carboplatin and Paclitaxel

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02053597 2015-09-17

TRIUMPH

Breast Neoplasms

NCT00458315 2015-05-08

Cisplatin/Paclitaxel/Gemcitabine +/- Avastin in Patients With Unknown Primary Tumor

Tumor-Agnostic

Neoplasms, Unknown Primary

NCT01953536 2014-12-19

Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)

Breast Neoplasms

NCT01953445 2014-12-08

Paclitaxel and BKM120 Before Surgery in Treating Patients With Stage II or III Estrogen Receptor-Positive and HER2-Negative Breast Cancer

Breast Neoplasms

NCT02013453 2014-12-02

A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer

Head & Neck

Head and Neck Neoplasms

NCT00006374 2014-01-15

Combination Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00084565 2013-07-10

Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer

Genitourinary

Prostatic Neoplasms

NCT01137994 2013-03-13

A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast Cancer

Breast Neoplasms

NCT01700010 2013-01-17

Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer

Genitourinary

Urinary Bladder Neoplasms, Neoplasms

NCT01163929 2012-10-24

A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast Cancer

Breast Neoplasms

NCT01169870 2012-01-04

Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer Patients